These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 14525632)

  • 1. Buspirone treatment for apneustic breathing in brain stem infarct.
    El-Khatib MF; Kiwan RA; Jamaleddine GW
    Respir Care; 2003 Oct; 48(10):956-8. PubMed ID: 14525632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of apneustic respiratory disturbance with a serotonin-receptor agonist.
    Wilken B; Lalley P; Bischoff AM; Christen HJ; Behnke J; Hanefeld F; Richter DW
    J Pediatr; 1997 Jan; 130(1):89-94. PubMed ID: 9003856
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apneusis responding to buspirone in multiple sclerosis.
    O'Sullivan RJ; Brown IG; Pender MP
    Mult Scler; 2008 Jun; 14(5):705-7. PubMed ID: 18424481
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ataxia from lithium toxicity successfully treated with high-dose buspirone: a single-case experimental design.
    Megna J; O'dell M
    Arch Phys Med Rehabil; 2001 Aug; 82(8):1145-8. PubMed ID: 11494197
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of a serotonin 1A receptor agonist to treat restless legs syndrome.
    Shioda K; Nisijima K; Yamauchi Y; Ohtuka K; Kato S
    J Clin Psychopharmacol; 2006 Dec; 26(6):673-5. PubMed ID: 17110833
    [No Abstract]   [Full Text] [Related]  

  • 6. The combination of buspirone and bupropion in the treatment of depression.
    Fava M
    Psychother Psychosom; 2007; 76(5):311-2. PubMed ID: 17700052
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of buspirone and fluoxetine for breathing problems in Rett syndrome.
    Gökben S; Ardıç UA; Serdaroğlu G
    Pediatr Neurol; 2012 Mar; 46(3):192-4. PubMed ID: 22353299
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Buspirone and serotonin in spinocerebellar ataxia.
    Gazulla J; Modrego P
    J Neurol Sci; 2008 May; 268(1-2):199-200; author reply 200-1. PubMed ID: 18222483
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of cognitive dysfunction in chronic schizophrenia by augmentation of atypical antipsychotics with buspirone, a partial 5-HT(1A) receptor agonist.
    Piskulić D; Olver JS; Maruff P; Norman TR
    Hum Psychopharmacol; 2009 Aug; 24(6):437-46. PubMed ID: 19637398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy.
    Heo JH; Lee ST; Chu K; Kim M
    J Neurol Sci; 2008 Aug; 271(1-2):87-90. PubMed ID: 18466925
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Buspirone in ODD.
    Dunne JE
    J Am Acad Child Adolesc Psychiatry; 1999 Aug; 38(8):942. PubMed ID: 10434482
    [No Abstract]   [Full Text] [Related]  

  • 12. The role of buspirone for the treatment of cerebellar ataxia in an older individual.
    Holroyd-Leduc JM; Liu BA; Maki BE; Zecevic A; Herrmann N; Black SE
    Can J Clin Pharmacol; 2005; 12(3):e218-21. PubMed ID: 16278493
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Buspirone: a new possibility in the treatment of anxiety].
    Faludi G
    Orv Hetil; 1994 Aug; 135(33):1807-13. PubMed ID: 8072756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An open clinical trial of buspirone in children with attention-deficit/hyperactivity disorder.
    Malhotra S; Santosh PJ
    J Am Acad Child Adolesc Psychiatry; 1998 Apr; 37(4):364-71. PubMed ID: 9549956
    [No Abstract]   [Full Text] [Related]  

  • 15. Two weeks of buspirone protects against posthypoxic ventilatory pauses in the C57BL/6J mouse strain.
    Moore MW; Chai S; Gillombardo CB; Carlo A; Donovan LM; Netzer N; Strohl KP
    Respir Physiol Neurobiol; 2012 Jul; 183(1):35-40. PubMed ID: 22595368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the 5-HT1A agonist, buspirone hydrochloride, in migraineurs with anxiety: a randomized, prospective, parallel group, double-blind, placebo-controlled study.
    Lee ST; Park JH; Kim M
    Headache; 2005 Sep; 45(8):1004-11. PubMed ID: 16109114
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apneustic breathing. A characteristic feature of brainstem compression in achondroplasia?
    Mador MJ; Tobin MJ
    Chest; 1990 Apr; 97(4):877-83. PubMed ID: 2323256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic buspirone treatment normalizes open field behavior in olfactory bulbectomized rats: assessment with a quantitative autoradiographic evaluation of the 5-HT1A binding sites.
    Sato H; Skelin I; Debonnel G; Diksic M
    Brain Res Bull; 2008 Mar; 75(5):545-55. PubMed ID: 18355630
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of spinocerebellar ataxia with buspirone.
    Assadi M; Campellone JV; Janson CG; Veloski JJ; Schwartzman RJ; Leone P
    J Neurol Sci; 2007 Sep; 260(1-2):143-6. PubMed ID: 17512011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The partial 5-hydroxytryptamine1A receptor agonist buspirone does not antagonize morphine-induced respiratory depression in humans.
    Oertel BG; Schneider A; Rohrbacher M; Schmidt H; Tegeder I; Geisslinger G; Lötsch J
    Clin Pharmacol Ther; 2007 Jan; 81(1):59-68. PubMed ID: 17186000
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.